|
24 Aug 2020 |
NantKwest and ImmunityBio Sign Collaboration Agreement for Joint Development, Manufacturing, Marketing, and Commercialization of COVID-19 Vaccine and Related Therapeutics
|
|
21 Aug 2020 |
Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies to Treat COVID-19 and Cancer Therapeutics
|
|
19 Aug 2020 |
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases
|
|
18 Aug 2020 |
LG Chem Life Sciences and TransThera Biosciences Announce License Agreement for Potential Treatment of NASH and Other Chronic Inflammatory Conditions
|
|
18 Aug 2020 |
Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration
|
|
17 Aug 2020 |
Dragonfly Therapeutics and Bristol Myers Squibb Announce Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy Program
|
|
17 Aug 2020 |
Abeona Therapeutics and Taysha Gene Therapies Enter into Licensing and Inventory Purchase Agreements for ABO-202, a Clinical Stage, Novel, One-time Gene Therapy for CLN1 Disease
|
|
17 Aug 2020 |
Sanofi to acquire Principia Biopharma
|
|
12 Aug 2020 |
GeneCentric Therapeutics Enters into Research Collaboration with Janssen on Genomic Drug Response Biomarkers for Non-Muscle Invasive Bladder Cancer
|
|
11 Aug 2020 |
Bayer to Acquire UK-Based Biotech KaNDy Therapeutics Ltd.
|
|
11 Aug 2020 |
Ligand to Acquire Pfenex Inc.
|
|
10 Aug 2020 |
Verastem Oncology Signs Definitive Agreement to Sell COPIKTRA® (duvelisib) Rights to Secura Bio to Focus on Development of VS-6766 and Defactinib in KRAS Mutant Solid Tumors
|
|
06 Aug 2020 |
Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases
|
|
06 Aug 2020 |
T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies
|
|
06 Aug 2020 |
GentiBio Launches with $20M Seed Funding from OrbiMed, Novartis Venture Fund and RA Capital Management, L.P. to Develop Engineered Regulatory T cells to Deliver Immune Tolerizing Therapies for Autoimmune and Inflammatory Diseases
|
|
06 Aug 2020 |
Taysha Gene Therapies Announces Oversubscribed $95 Million Series B Financing to Bolster Initial Clinical Studies in GM2 Gangliosidosis and Advance Pipeline of Gene Therapies for Monogenic CNS Disease in Both Rare and Large Patient Populations
|
|
06 Aug 2020 |
Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market
|
|
04 Aug 2020 |
Redx signs out licensing agreement with AstraZeneca
|
|
04 Aug 2020 |
LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy
|
|
30 Jul 2020 |
Sangamo Announces Global Collaboration With Novartis to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders
|
|
30 Jul 2020 |
Spring Bank Pharmaceuticals and F-star Therapeutics Agree to Combine to Pursue Mission of Creating Next Generation Immunotherapies
|
|
29 Jul 2020 |
Lilly's P-tau217 Blood Test Shows High Accuracy in Diagnosis of Alzheimer's Disease in Data Published in JAMA
|
|
28 Jul 2020 |
Terns Pharmaceuticals and Hansoh Pharma Announce Collaboration and License Agreement for TRN-000632 in Greater China
|
|
27 Jul 2020 |
Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA
|
|
24 Jul 2020 |
Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics
|
